Tapewire

Nasdaq · USD

DWTX

Dogwood Therapeutics, Inc.

Export transactions ↓
Tapewire entity
6845
SEC CIK
0001818844
Parsed reports
116

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 28, 2021 Filed Feb 2, 2021 00:54 UTC Exercise / conversionWarrant to Purchase Common Stock · Derivative 1,602 $0.00 Strike: $7.80 $0.00
Disclosure

SEC source: 0001104659-21-010383 · tm214953-1_4seq1.xml · derivative · entry 2

Keefer David R · CIK 0001825986 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Ethica Group, LLC

Disclosed balance after: 0

Underlying: Common Stock · 1,602 shares

Expires 2021-01-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: The Reporting Person provided notice of exercise to the Issuer on January 20, 2021 and the Company authorized the issuance of the shares pursuant to such exercise on January 28, 2020.

F1 · ownership.nature: The securities are owned directly by Ethica Group, LLC ("Ethica"), the Reporting Person is managing member of Ethica and may be deemed to beneficially own the securities held directly by Ethica.

Read SEC document
January 28, 2021 Filed Feb 2, 2021 00:54 UTC Exercise / conversionCommon Stock 1,602 $7.80 $12,495.60
Disclosure

SEC source: 0001104659-21-010383 · tm214953-1_4seq1.xml · nonDerivative · entry 1

Keefer David R · CIK 0001825986 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Ethica Group, LLC

Disclosed balance after: 7,808

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: The securities are owned directly by Ethica Group, LLC ("Ethica"), the Reporting Person is managing member of Ethica and may be deemed to beneficially own the securities held directly by Ethica.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 00:44 UTC
Grosswald RalphVP of Finance
GrantStock Option (right to buy) · Derivative 209 $0.00 Strike: $10.00 $0.00
Disclosure

SEC source: 0001104659-21-003575 · tm212264d4_4.xml · derivative · entry 1

Grosswald Ralph · CIK 0001826084 · VP of Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,621

Underlying: Common Stock · 209 shares

Expires 2030-12-21

F1 · kind: Stock options granted pursuant to the reporting person's employment agreement. Pursuant to that employment agreement, the reporting person was entitled to receive a total of 41,621 stock options. In error, the Issuer previously granted only 41,412. This grant was made solely to correct the error in the number of stock options granted under the reporting person's employment agreement.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 00:45 UTC
Duncan Gregory ScottDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 21,796 $0.00 Strike: $10.00 $0.00
Disclosure

SEC source: 0001104659-21-003576 · tm212264-5_4seq1.xml · derivative · entry 1

Duncan Gregory Scott · CIK 0001831127 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 435,921

Underlying: Common Stock · 21,796 shares

Expires 2030-12-21

F1 · kind: Stock options granted pursuant to the reporting person's employment agreement. Pursuant to that employment agreement, the reporting person was entitled to receive a total of 435,921 stock options. In error, the Issuer previously granted only 414,125. This grant was made solely to correct the error in the number of stock options granted under the reporting person's employment agreement.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 00:44 UTC
Walsh AngelaVP of Finance
GrantStock Option (right to buy) · Derivative 209 $0.00 Strike: $10.00 $0.00
Disclosure

SEC source: 0001104659-21-003573 · tm212264d3_4.xml · derivative · entry 1

Walsh Angela · CIK 0001825987 · VP of Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,621

Underlying: Common Stock · 209 shares

Expires 2030-12-21

F1 · kind: Stock options granted pursuant to the reporting person's employment agreement. Pursuant to that employment agreement, the reporting person was entitled to receive a total of 41,621 stock options. In error, the Issuer previously granted only 41,412. This grant was made solely to correct the error in the number of stock options granted under the reporting person's employment agreement.

Read SEC document
January 06, 2021 Filed Jan 9, 2021 00:23 UTC
Duncan Gregory ScottDirector · Chief Executive Officer
Exercise / conversionWarrant to Purchase Common Stock · Derivative 801 $0.00 Strike: $7.80 $0.00
Disclosure

SEC source: 0001104659-21-002579 · tm212264-1_4seq1.xml · derivative · entry 2

Duncan Gregory Scott · CIK 0001831127 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 801 shares

Expires 2021-01-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 06, 2021 Filed Jan 9, 2021 00:23 UTC
Duncan Gregory ScottDirector · Chief Executive Officer
Exercise / conversionCommon Stock 801 $7.80 $6,247.80
Disclosure

SEC source: 0001104659-21-002579 · tm212264-1_4seq1.xml · nonDerivative · entry 1

Duncan Gregory Scott · CIK 0001831127 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,904

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 01, 2021 Filed Jan 13, 2021 00:43 UTC
Gendreau Roger MichaelChief Medical Officer
GrantStock Option (right to buy) · Derivative 41,734 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0001104659-21-003572 · tm212264d2_4.xml · derivative · entry 1

Gendreau Roger Michael · CIK 0001826131 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,734

Underlying: Common Stock · 41,734 shares

Expires 2031-01-01

F1 · kind: Stock option granted pursuant to the reporting person's employment agreement. The stock option vests one-third on January 1, 2022 and 1/24th monthly thereafter.

F1 · derivative.exercise_date: Stock option granted pursuant to the reporting person's employment agreement. The stock option vests one-third on January 1, 2022 and 1/24th monthly thereafter.

Read SEC document
December 21, 2020 Filed Dec 22, 2020 01:12 UTC
Duncan Gregory ScottDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 414,125 $0.00 Strike: $10.00 $0.00
Disclosure

SEC source: 0001104659-20-138202 · tm2039099-4_4.xml · derivative · entry 1

Duncan Gregory Scott · CIK 0001831127 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 414,125

Underlying: Common Stock · 414,125 shares

Expires 2030-12-21

Read SEC document
December 21, 2020 Filed Dec 22, 2020 01:11 UTC
Grosswald RalphVice President of Operations
GrantStock Option (right to buy) · Derivative 41,412 $0.00 Strike: $10.00 $0.00
Disclosure

SEC source: 0001104659-20-138201 · tm2039099-3_4.xml · derivative · entry 1

Grosswald Ralph · CIK 0001826084 · Vice President of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,412

Underlying: Common Stock · 41,412 shares

Expires 2030-12-21

Read SEC document
December 21, 2020 Filed Dec 22, 2020 01:11 UTC
Walsh AngelaVP of Finance
GrantStock Option (right to buy) · Derivative 41,412 $0.00 Strike: $10.00 $0.00
Disclosure

SEC source: 0001104659-20-138200 · tm2039099-2_4.xml · derivative · entry 1

Walsh Angela · CIK 0001825987 · VP of Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,412

Underlying: Common Stock · 41,412 shares

Expires 2030-12-21

Read SEC document
December 17, 2020 Filed Dec 22, 2020 01:10 UTC PurchaseCommon Stock 1,500 $11.98 $17,970.00
Disclosure

SEC source: 0001104659-20-138199 · tm2039099-1_4.xml · nonDerivative · entry 1

Pridgen William · CIK 0001826115 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 727,192

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.